Roger S. Newton, Director at Esperion Therapeutics, Inc. (ESPR), sold 2,827 shares at $50.01 ($142K) on 2018-11-01, disclosed to the SEC on 2018-11-02.
Open-market sale of $142k ESPR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.01 | 2,600 | $130K | 91.9% |
| 2 | $50.76 | 227 | $12K | 8.1% |
| Total | $50.07 avg | 2,827 | $142K | 100% |
| Filing → |
| ESPR | SELL | 2018-08-29 | $904K | — | Filing → |
| ESPR | SELL | 2018-08-22 | $365K | — | Filing → |
| ESPR | SELL | 2018-03-29 | $1.8M | — | Filing → |